Abstract
This review article is aimed to delineate the potential role of hormones in the treatment and diagnosis of cardiovascular diseases with special emphasis on the nitric oxide (NO) involved mechanisms. This review will also offer an overview on current and future hormone usages, pathophysiology, clinical features, absorption mechanisms and adverse effects. The hormone therapies against cardiovascular diseases as well as their treatment strategies, delivery routes and carriers were thoroughly discussed.
Ongoing and future basic and clinical research with hormone will provide important insights into efficient treatment strategies against cardiovascular diseases. It was necessary to explore advanced delivery systems, such as drug eluting stent, microneedles, nanotechnology and stem cell preconditioning, for an efficient delivery of hormones against cardiovascular diseases. The future is enlightened with the advent of novel, safer and more effective carriers for hormone delivery as well as learning how to maximize the therapeutic efficacy against cardiovascular diseases.Keywords: Hormone, delivery, cardiovascular, regulation, preconditioning, stem cell transplantation.
Current Pharmaceutical Biotechnology
Title:Hormone Therapy and Delivery Strategies against Cardiovascular Diseases
Volume: 18 Issue: 4
Author(s): Gayathri Acharya, Nurhasni Hasan, Jin-Wook Yoo and Chi H. Lee*
Affiliation:
- 2464 Charlotte St. Division of Pharmaceutical Sciences, University of Missouri at Kansas City, Kansas City, MO 64108,United States
Keywords: Hormone, delivery, cardiovascular, regulation, preconditioning, stem cell transplantation.
Abstract: This review article is aimed to delineate the potential role of hormones in the treatment and diagnosis of cardiovascular diseases with special emphasis on the nitric oxide (NO) involved mechanisms. This review will also offer an overview on current and future hormone usages, pathophysiology, clinical features, absorption mechanisms and adverse effects. The hormone therapies against cardiovascular diseases as well as their treatment strategies, delivery routes and carriers were thoroughly discussed.
Ongoing and future basic and clinical research with hormone will provide important insights into efficient treatment strategies against cardiovascular diseases. It was necessary to explore advanced delivery systems, such as drug eluting stent, microneedles, nanotechnology and stem cell preconditioning, for an efficient delivery of hormones against cardiovascular diseases. The future is enlightened with the advent of novel, safer and more effective carriers for hormone delivery as well as learning how to maximize the therapeutic efficacy against cardiovascular diseases.Export Options
About this article
Cite this article as:
Acharya Gayathri, Hasan Nurhasni, Yoo Jin-Wook and Lee H. Chi*, Hormone Therapy and Delivery Strategies against Cardiovascular Diseases, Current Pharmaceutical Biotechnology 2017; 18 (4) . https://dx.doi.org/10.2174/1389201018666170224103306
DOI https://dx.doi.org/10.2174/1389201018666170224103306 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Controversies in Pharmacological Treatment of Inflammatory Component of Macular Edema
Current Pharmaceutical Design Perioperative Considerations in Diabetic Patients
Current Diabetes Reviews Mammalian Cytosolic Glutathione Transferases
Current Protein & Peptide Science Cardiomyopathy of Pregnancy
Current Women`s Health Reviews Psoriatic Arthritis – Review of the Immunologic, Clinic and Therapeutic Aspects of an Inflammatory Systemic Disease
Current Rheumatology Reviews The Cardiovascular Effects of Metformin: Further Reasons to Consider An Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus
Current Vascular Pharmacology Resveratrol, a Phytochemical Inducer of Multiple Cell Death Pathways: Apoptosis, Autophagy and Mitotic Catastrophe
Current Medicinal Chemistry Pleiotropic Effects of Rimonabant: Clinical Implications
Current Pharmaceutical Design Hydroethanolic Extract of <i>Lampaya Medicinalis</i> Phil. (<i>Verbenaceae</i>) Decreases Proinflammatory Marker Expression in Palmitic Acid-exposed Macrophages
Endocrine, Metabolic & Immune Disorders - Drug Targets Serum Uric Acid and Risk of Coronary Heart Disease
Current Pharmaceutical Design Patent Selections
Recent Patents on Cardiovascular Drug Discovery Ion Channel Architecture of the Renal Microcirculation
Current Hypertension Reviews The Effect of DPP-4i on Endothelial Function and Arterial Stiffness in Patients with Type 2 Diabetes: A Systematic Review of Randomized Placebo-controlled Trials
Current Pharmaceutical Design Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases
Current Neuropharmacology Oxidative Stress and Vascular Disease
Current Hypertension Reviews Statins and Portal Hypertension: A New Pharmacological Challenge
Current Vascular Pharmacology Pleuroparenchymal Fibroelastosis: Its Pathological Characteristics
Current Respiratory Medicine Reviews Subtype Selectivity in Phosphodiesterase 4 (PDE4): A Bottleneck in Rational Drug Design
Current Pharmaceutical Design Cord Blood as Diagnostic Window for Preeclampsia
Recent Patents on Biomarkers Compounds that Combine Aldose Reductase Inhibitory Activity and Ability to Prevent the Glycation (Glucation and/or Fructation) of Proteins as Putative Pharmacotherapeutic Agents
Drug Design Reviews - Online (Discontinued)